485 Inhibition of urokinase and matrix metalloproteinases prevents left ventricular hypertrophy and cardiac failure during hypertension

Stéphane Heymans; Frans Van de Werf; Lieve Moons; Peter Carmeliet

doi:10.1016/s1567-4215(04)90354-2

Related publications

Article2006

Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis

Stéphane Heymans, Matthias Pauschinger, Armando De Palma, Angela Kallwellis-Opara, Susanne Rutschow, Melissa Swinnen, Davy Vanhoutte, Fangye Gao, Raimund Torpai, Andrew H. Baker, Elisabeth Padalko, Johan Neyts, Heinz‐Peter Schultheiß, Frans Van de Werf, Peter Carmeliet, Yigal M. Pinto

Article1999

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

Stéphane Heymans, Aernout Luttun, Dieter Nuyens, Gregor Theilmeier, Esther E. Creemers, Lieve Moons, G.D. Dyspersin, Jack P.M. Cleutjens, M. Shipley, Anne Angellilo, Moshe Levi, O. Nüβe, Andrew H. Baker, Eli Keshet, Florea Lupu, J‐M. Herbert, Jos F.M. Smits, Steven D. Shapiro, Myriam Baes, M. Borgers, D Collen, Mat J.A.P. Daemen,

Article1997

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

Peter Carmeliet, Lieve Moons, Roger Lijnen, Myriam Baes, Vincent Lemaı̂tre, Peter G. Tipping, Angela F. Drew, Yves Eeckhout, Steve D. Shapiro, Florea Lupu, Désiré Collen

Article2012

Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure

Blanche Schroen, Maarten F. Corsten, Wouter Verhesen, León J. De Windt, Y M Pinto, Serena Zacchigna, Thomas Thum, Peter Carmeliet, Anna‐Pia Papageorgiou, Stéphane Heymans

Article2004

Inhibition of proteinases prevents cardiac injury during viral myocarditis

Stéphane Heymans, Frans Van de Werf, Peter Carmeliet